AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports
· Reuters
AI Briefing
- • AstraZeneca and Daiichi Sankyo near UK pricing deal for breast cancer drug Enhertu, Bloomberg News reports.
- • UK's NICE previously denied coverage for Enhertu due to cost-effectiveness concerns for NHS.
- • Discussions with NHS England are ongoing for a potential pricing agreement.
Source Summary
Drugmakers AstraZeneca and Daiichi Sankyo are nearing an agreement with the UK's pricing regulator for their breast cancer treatment Enhertu, Bloomberg News reported on Wednesday, citing multiple people familiar with the matter.
Advertisement